Agilon Health, Inc.

NYSE:AGL

Medical - Care Facilities

Healthcare
$90.53 +2.16%

+$2.26 today

Market cap
$1.52B
Beta
3.04
P/E (TTM)
-4.8
EPS (TTM)
-$22.50
52W Low $7.48High $118.25

Volume 0.79M

Average 0.41M

AGL Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Agilon Health, Inc.NYSE: AGL

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense turns negative

Q1 FY2026 income tax expense was -$28K, compared with $196K a year earlier. Trailing-twelve-month income tax expense was $1.03M. Over 3 fiscal years it compounded at -8.6% a year.

Context

  • Income tax expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near -$28K or moves back toward the trailing-twelve-month quarterly average of $256.75K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$28K-102.1% QoQ
Last fiscal yearDec 2025
$1.25M-13.8% YoY
LTMMar 2026
$1.03M-42.3% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-114.3%——
1 year-13.8%——
3-year CAGR-8.6%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
1.25M USD
Year-over-year change
-13.8%
4-year CAGR
+9.0%

Income Tax Expense vs competitors

How AGL compares with its peers on the latest reported figures

  • AGL's LTM Mar 2026 income tax expense of $1.03M is the 2nd highest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of -42.3% is the 5th highest of 7, against a peer median of -14.8%.
  • Income tax expense amounts to 0.0% of revenue for AGL, versus a peer median of 1.6%.
AGL Competitors Peer median
Income Tax Expense for AGL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$1.26M -10.5%—1.6%
AGLAgilon Health, Inc.LTM Mar 2026$1.03M -42.3%-8.6%0.0%
MCTACharming Medical Limited Class A Ordinary SharesFY2024$236.08K +29.9%—3.8%
ANNXAnnexon, Inc.LTM Mar 2026$0 ———
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$0 ———
NAKANakamoto Inc.LTM Mar 2026$0 ——0.0%
ENGNenGene Holdings Inc.LTM Apr 2026-$258K -204.0%——
DHDefinitive Healthcare Corp.LTM Mar 2026-$2.51M +95.2%—1.1%
SLPSimulations Plus, Inc.LTM Feb 2026-$3.51M -376.3%—4.4%
DBVTDBV Technologies S.A.LTM Mar 2026-$3.55M -19.2%+91.4%—
Peer median (excluding AGL) $0-14.8%+91.4%1.6%

Competitors are the stored peer set for AGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.52B2.39B4.32B6.06B5.93B
Cost of Revenue1.46B2.28B4.25B6.06B6.12B
Gross Profit65.74M111.36M69.67M4.84M(188.61M)
Gross Margin4.3%4.7%1.6%0.1%-3.2%
Research & Development00000
Selling, General & Admin427.5M207.79M285.76M268.91M238.54M
Operating Expenses437.99M216.74M301.8M296.97M232.46M
Depreciation & Amortization14.67M13.77M20.16M24.46M28.59M
EBITDA(362.16M)(72.41M)(167.64M)(218.19M)(368.86M)
EBITDA Margin-23.8%-3.0%-3.9%-3.6%-6.2%
Operating Income(372.24M)(105.38M)(232.13M)(292.13M)(421.08M)
Operating Margin-24.5%-4.4%-5.4%-4.8%-7.1%
Interest Income00000
Interest Expense6.15M4.48M6.66M6.18M6.64M
Other Income / Expenses(10.73M)14.71M37.67M43.3M16.98M
Income Before Tax(382.98M)(90.67M)(194.46M)(248.83M)(404.1M)
Pre-Tax Margin-25.2%-3.8%-4.5%-4.1%-6.8%
Income Tax Expense886K1.64M791K1.45M1.25M
Net Income(406.49M)(106.55M)(262.6M)(260.15M)(405.35M)
Net Margin-26.7%-4.5%-6.1%-4.3%-6.8%
EPS (Basic)(27.25)(6.50)(16.00)(15.75)(24.50)
EPS (Diluted)(27.25)(6.50)(16.00)(15.75)(24.50)
Weighted Avg Shares14.92M16.33M16.36M16.44M16.56M
Weighted Avg Shares (Diluted)14.92M16.33M16.36M16.44M16.56M

Agilon Health, Inc.

NYSE:AGL

Intrinsic Alpha fair value

Locked

Current Price

$90.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.